There have already been uncommon post-marketing reviews of cases of intestinal obstruction, and exacerbation of diverticulitis, many of which have demanded healthcare intervention to get rid of the tablet. Patients with underlying GI disorders including esophageal cancer or colon cancer with a little gastrointestinal lumen are at higher possibility